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Introduction
Benchmarking is a well-established management tool, 
generally used to improve productivity, efficacy and 
product quality. In the field of esophageal cancer surgery, 
different approaches to adopt this concept for outcome 
research have been published in recent years. The key 
element of benchmarking is the comparison with the best 
possible outcome—the benchmark. Only the contrast to 
the best reveals the true potential for improvement. Just 
as a company has no interest in being average, it lays in 
every surgeon’s nature to desire the best possible outcome 
for his patients. However, in the majority of studies with 
a focus on benchmarking minimally invasive esophageal 
cancer surgery, this principle is not entirely respected. 
The given thresholds are mostly based on large unselected 
data collections and simple averages drawn from their 
results. In contrast, the essence of a valid benchmark lays 
in the definition of the optimum, which is a most difficult 
endeavor—especially in the field of surgery. 
Validity of benchmarks 
Benchmarking is a cyclic process for quality improvement 
that consists of three important steps: First, defining the 
best; second, comparing to the best; and third, learning 
from the best (1,2). By comparison of own results to an 
optimal threshold, flaws in quality may be detected. These 
deficiencies may be corrected by adopting processes that 
were implemented by other centers that perform within 
the benchmark (1). There are numerous ways to create 
benchmarks in surgery, but all efforts pursue one common 
goal: to improve outcome (3). While simple comparison 
with other centers may detect quality deficits, only the 
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orientation towards a best possible result reflects the true 
potential for improvement (3). 
In surgery, the patient and the surgeon are the two basic 
factors with a paramount impact on outcome: patients 
may present with various risk factors and a surgical team’s 
experience in preparing and performing the intervention, but 
also in postoperative caretaking, may vary substantially (3). 
Optimizing a patient’s nutritional and metabolic state 
prior to surgery has been shown to improve postoperative 
outcome (4-6). However, the best results for any operation 
or intervention are obtained when “ideal” patients are 
treated by experienced surgeons in international high-
volume centers (3,7-9). In general, “ideal” patients are 
those with the fewest expected postoperative complications. 
Depending on the type of surgery, factors such as 
comorbidities (diabetes, chronic obstructive pulmonary 
disease, etc.), medication (steroid intake, anticoagulant 
therapy, etc.), lifestyle (smoking, obesity, etc.) or patient 
characteristics (age, sex) may have a great influence on 
outcome. For example, optimal results for hemihepatectomy 
may be assumed in living liver donors, since their mandatory 
prerequisite is to be young and healthy (7). Therefore, a 
benchmark calculation should exclusively be based on such 
“ideal” patients (3,7-9). 
Over the last decade, centralization in healthcare has 
moved into the center of attention (10). It is commonly 
accepted that outcome after surgery does not only depend 
on the surgeon’s performance, but rather on a finely tuned 
collaboration of all involved disciplines (11,12). As a general 
rule, postoperative complication rates and overall morbidity 
are lower, if the surgical intervention is frequently 
performed by a specialized team. Therefore, to grant their 
validity, only data from high-volume centers should be used 
to establish benchmark cut-off values (3,8). 
Another restriction often imposed on published quality 
thresholds are national borders. Yet, good surgical quality 
is never restricted to one single country; therefore, best 
results are most realistically represented in international 
benchmarks including high-volume centers from all over 
the world (3).
Careful selection of the performance metrics of 
benchmarking is another important issue. The mortality 
rate alone does not reflect the true quality of surgical 
outcome, and therefore, postoperative morbidity and 
health related quality of life have lately moved into focus. 
Outcome measures for benchmark analysis should be 
easily available and routinely collected, such as overall 
postoperative morbidity, severe complications, and length of 
hospital or intensive care unit stay (3). Also, surgery-specific 
quality indicators are of interest (e.g., anastomotic fistula in 
esophageal surgery or graft failure in liver transplantation) (3). 
It is highly important that outcome parameters are clearly 
defined and that each center’s results are documented 
separately; otherwise, center-specific differences cannot be 
included in the benchmark (3).
The determination of the benchmark cut-offs is another 
critical step. The idea of a benchmark is to represent a 
realistic best possible outcome. Therefore, the benchmark 
value cut-off has been set at the 75th percentile of the 
median proportion of each included center (3,8); as a result 
of which not only the top few, but 75% of the best outcome 
achieved in high volume centers on ideal patients represent 
the benchmark.
It is evident that such best possible outcome is not always 
achievable, in particular when operating on multimorbid 
patients or in high risk situations (3). Yet, the benchmark 
sets an anchor for surgeons to know what is possible. When 
applying benchmarks to own patients, it is important 
that the comparison group exclusively consists of low risk 
“benchmark patients”—just like the population that was 
deployed for calculation of the benchmark (3). Apples 
must be compared with apples of the same quality. Patients 
with higher comorbidity are likely to have inferior results. 
However, in benchmarking, the surgeon and his team 
are being put to the test (8). If they perform within the 
benchmark for “ideal” patients, it may be assumed that their 
results are also within the benchmark when operating on 
patients with higher comorbidity. Of note, the fundamental 
idea of benchmarking in surgery is not to judge, monitor, 
or supervise a center’s or individual surgeon’s performance, 
but to offer a pragmatic and individually accessible measure 
for quality and thereby fuel every surgeon’s pursuit of 
perfection (3). 
Benchmark analyses in minimally invasive 
esophagectomy (MIE)
MIE for surgical treatment of esophageal cancer was 
introduced around 25 years ago with the aim to reduce 
procedure-related morbidity (13,14). Lately, MIE has 
evolved to the procedure of choice in many centers around 
the world (8), although this trend is supported by a handful 
of randomized studies only (15-17).
It is important to keep in mind that MIE is an umbrella 
term for many different operations, including transhiatal 
and transthoracic esophagectomy, hybrid, total minimally 
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invasive or robotic-assisted procedures. All these techniques 
are referred to as “minimally invasive” in the current 
literature, which makes comparison often difficult and 
sometimes even impossible. 
Outcome research on esophageal cancer surgery is 
typically performed on the basis of large national patient 
registries (18-21). However, these national data collections 
report the outcome of institutions with variable expertise 
and include patients with a large range of risk factors that 
underwent a motley variety of MIE procedures. Moreover, 
standardized or well-defined outcome parameters are not 
available in most studies. Consequently, these analyses, even 
if reporting “benchmarks”, are usually biased and provide 
only a blurred snapshot of the situation in a specific region 
of the world. 
An alternative way to provide aggregated quality 
thresholds for esophagectomies is to gather data from 
renowned expert centers or high-volume institutions. 
Likewise, values on outcome after MIE—also referred to as 
benchmarks—were recently presented by the Esophagectomy 
Compl ica t ions  Consensus  Group (ECCG) (22) . 
Established from a high-quality international database 
including 24 expert centers from 14 different countries, 
this data collection holds a great amount of valuable 
information. Yet, for the determination of thresholds, the 
authors did not differentiate surgical approach or technique, 
nor did they provide different cut-off values for a specific 
patient’s risk level. For instance, outcomes of patients with 
various comorbidity and different American Society of 
Anesthesiologists (ASA) scores that underwent all types of 
(open or minimally invasive) esophagectomy, or with tumors 
located in the proximal as well as distal esophagus etc. were 
mixed together. Further, points of reference are presented 
as a percentage of all patients included in the database; 
an approach that does not compensate for center specific 
differences. For one, hospitals contributing more patients to 
the dataset influence the threshold in a much greater extent; 
for the other, centers with better quality results may perish 
in the unity. For creating a valid benchmark that truly serves 
as point of reference of best possible outcome, the selection 
of the surgical approach as well as patients presumed to 
have the least amount of postoperative complications is of 
utter importance (3). Also, the results should be assessed 
for each center individually and each hospital’s median 
result (or percentage of binominal outcomes) should be 
used for benchmark value calculation (3). Otherwise, these 
thresholds are rather a summary of the collected data than a 
true benchmark. 
In an attempt to create a reliable benchmark for MIE, 
we recently performed a retrospective multicenter cohort 
study with an exclusive focus on total minimally invasive 
transthoracic esophagectomy (ttMIE) (Ivor Lewis and 
McKeown procedures only) (8). Some 1,057 patients from 
thirteen international expert centers for esophageal surgery 
(case load >20 esophagectomies per year) were included. 
We classified the outcome parameters according to the 
complications basic platform published by the ECCG (23) 
and postoperative morbidity was graded according to the 
Clavien-Dindo (CD) classification (24). “Ideal” patients 
meeting benchmark criteria were defined as having a low risk 
profile [Eastern Cooperative Oncology Group (ECOG) grade 
≤1 and ASA score ≤2, age ≤65 years, and BMI 19–29 kg/m2]. 
Primary outcome measures for benchmark analysis were 
overall and major (CD ≥3a) morbidity, readmissions, 
anastomotic and pulmonary complications; all at 30 days after 
hospital discharge. In addition, positive resection margins, 
the number of examined lymph nodes, the 30- and 90-day 
Comprehensive Complication Index (CCI®) (25,26), and 
30- and 90-day mortality rates were calculated (Figure 1). 
Benchmarks were defined as the 75th percentile of the median 
outcome parameters of the participating centers (3,8). 
Our study was criticized because the reference points 
for benchmark values seemed high compared with other 
outcome research on MIE (27). However, this criticism 
reflects a common misinterpretation of the benchmark 
concept, because our cut-off values only represent upper 
limits of “best possible” results. This means that results 
from other centers should be within the thresholds of the 
benchmark (i.e., the best 75% of the median results of each 
center) to indicate acceptable outcome quality (28). 
Discussion
Reducing the continuously increasing cost in health care 
is one of the greatest socioeconomic challenges of our 
time. In addition, there is increasing pressure on health 
care providers to introduce advanced surgical procedures 
or tools, such as minimally invasive or robotic-assisted 
surgery. However, from an economical point of view, the 
implementation of new technologies is often difficult to 
justify, because the benefits of those techniques are mostly 
short term with fewer postoperative complications and 
faster recovery after surgery. Furthermore, the scientific 
evidence supporting the upsides of these technologies is still 
weak and it remains debatable whether the benefits may 
counterbalance the greater financial expenditures. 
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It has been shown that postoperative morbidity is a most 
critical factor in this debate. Thus, a strong correlation 
between overall postoperative morbidity and cost has 
just recently been demonstrated (29,30). Moreover, the 
reduction of postoperative complications not only complies 
with the strong economic requirements of today, but is of 
paramount importance for the patients’ health, quality of 
life, and even long-term survival (30,31). However, it is 
a difficult task to work on outcome improvement, if the 
precise nature and extent of the quality issues are unknown. 
Benchmarks, which stand for the best possible outcome, may 
represent points of reference that help centers or individual 
surgeons on their path towards quality improvement.
Even if the crucial steps to create a valid benchmark are 
respected, a newly created benchmark metric may feature 
some subjectivity (3). It may be criticized for an individual 
selection of contributing centers or countries, patient inclusion 
criteria, or benchmark value cut-off points. Therefore, an 
intensive discussion about the appropriate performance 
metrics of benchmarking is paramount. The importance 
of this issue has recently been addressed in a study on risk 
adjustments for cancer esophagectomy (32). Parameters, 
such as the ASA score, the ECOG performance status, the 
number of comorbidities and anastomotic leakage rate were 
the strongest predictors of postoperative mortality (32). 
When establishing a new benchmark, such influential 
outcome measures must be considered when deciding on 
inclusion or exclusion criteria for “ideal” patients. However, 
when comparing own outcome data to the benchmark, 
additional risk adjustment is not required, as only “ideal” 
patients meeting the identical inclusion criteria may be 
compared. Admittedly, centers that perform within the 
benchmark for “ideal” patients may not achieve the same 
level of quality in patients with higher comorbidity. This 
may be considered a drawback of the “ideal patient” 
benchmark approach. To answer this question, specific 
benchmarks for patients with higher perioperative risk 
would need to be established.
Another shortcoming of benchmarking relates to the 
effect of learning, which undoubtedly is a paramount factor 
in complex surgical procedures. Learning curves, particularly 
for novel technologies such as MIE (33) play a significant 
role in surgical benchmarking and it is evident that regular 
updates of benchmark cut-off parameters are necessary (28).
Center vs. individual surgeon volume is another 
aspect that has not been taken into account by previously 
published benchmark studies (7-9). Generally, due to the 
large experience of the surgical team, it is automatically 
assumed that high volume centers provide the highest level 
of surgical quality. However, the personal experience of an 
individual surgeon may play a more important role and a 
lower volume operated by a single surgeon may represent 
greater experience than a higher volume operated by many. 
Also, high volume centers often serve as training hospitals, 
which may bias results. Therefore, we recommend that 
future benchmark studies should also focus on individual 
surgeon volume. 
In conclusion, compiling a valid benchmark that truly 
represents an anchor for best possible outcome is a tricky 
endeavor not only for minimally invasive procedures. 
Any complication
≤55.7%
Anastomotic leakage
≤20.0%
Pulmonary complications
≤31.6%
Positive resection margins
≤3.1%
Lymph nodes examined
≥23
Severe complications
≤30.8%
Readmission rate
≤18.0%
Mortality rate
≤1.0%
Overall morbidity
≤40.8
Figure 1 Benchmark values at 30 days after surgery. Results better than the given threshold are considered to be within the benchmark.
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Careful evaluation of inclusion criteria to collect real 
benchmark data is essential.
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